Marco Falasca

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

Cancers

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

Chemistry (Weinheim an der Bergstrasse, Germany)

Curtin University

Istituto Di Ricerche Farmacologiche Mario Negri (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Curtin University Nov 06 2014

Australia

Professor in Metabolism :: School of Pharmacy & Biomedical Sciences

Queen Mary University of London May 01 2007 - Oct 31 2014

United Kingdom

Professor in Molecular Pharmacology :: Blizard Institute

University College London Mar 01 2001 - Apr 30 2007

United Kingdom

Senior Lecturer :: Department of Medicine

New York University Oct 01 1995 - Dec 18 1998

United States

Postdoctoral :: Deaprtment of Pharmacology

Education History

Istituto Di Ricerche Farmacologiche Mario Negri Sep 01 1991 - Sep 01 1994

Italy

PHD :: Endocrinology

Publications

Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, Ilaria Casari, Marco Falasca
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. International journal of molecular sciences 25 (4) (2024)
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, Ilaria Casari, Marco Falasca
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. International journal of molecular sciences 25 (4) (2024)
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, Ilaria Casari, Marco Falasca
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. International journal of molecular sciences 25 (4) (2024)
Dinesh Thapa, Leon N Warne, Marco Falasca
Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. International journal of molecular sciences 24 (19) (2023)
N Dianah B Abu Bakar, Rodrigo Carlessi, Jully Gogoi-Tiwari, Julia Köhn-Gaone, Vincent Williams, Marco Falasca, John K Olynyk, Grant A Ramm, Janina E E Tirnitz-Parker
TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis. Cancers 15 (6) (2023)
N Dianah B Abu Bakar, Rodrigo Carlessi, Jully Gogoi-Tiwari, Julia Köhn-Gaone, Vincent Williams, Marco Falasca, John K Olynyk, Grant A Ramm, Janina E E Tirnitz-Parker
TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis. Cancers 15 (6) (2023)
Pratibha Malhotra, Ranjith Palanisamy, Jose A Caparros-Martin, Marco Falasca
Bile Acids and Microbiota Interplay in Pancreatic Cancer. Cancers 15 (14) (2023)
Federico Selvaggi, Eugenia Melchiorre, Ilaria Casari, Sebastiano Cinalli, Massimiliano Cinalli, Gitana Maria Aceto, Roberto Cotellese, Ingrid Garajova, Marco Falasca
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance. Cancers 14 (23) (2022)
Federico Selvaggi, Eugenia Melchiorre, Ilaria Casari, Sebastiano Cinalli, Massimiliano Cinalli, Gitana Maria Aceto, Roberto Cotellese, Ingrid Garajova, Marco Falasca
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance. Cancers 14 (23) (2022)
Valerio Falasca, Marco Falasca
Targeting the Endocannabinoidome in Pancreatic Cancer. Biomolecules 12 (2) (2022)
Federico Selvaggi, Eugenia Melchiorre, Ilaria Casari, Sebastiano Cinalli, Massimiliano Cinalli, Gitana Maria Aceto, Roberto Cotellese, Ingrid Garajova, Marco Falasca
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance. Cancers 14 (23) (2022)
Elettra Barberis, Shahzaib Khoso, Antonio Sica, Marco Falasca, Alessandra Gennari, Francesco Dondero, Antreas Afantitis, Marcello Manfredi
Precision Medicine Approaches with Metabolomics and Artificial Intelligence. International journal of molecular sciences 23 (19) (2022)
Marco Falasca, Mauro Maccarrone
Cannabinoids and Cancer. Cancers 13 (17) (2021)
Chamini J Perera, Marco Falasca, Suresh T Chari, Jerry R Greenfield, Zhihong Xu, Romano C Pirola, Jeremy S Wilson, Minoti V Apte
Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis. Cancers 13 (20) (2021)
Kirsten Cameron, Lina Rozano, Marco Falasca, Ricardo L Mancera
Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study. International journal of molecular sciences 22 (13) (2021)
Xin Chien Lee, Evelyn Werner, Marco Falasca
Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer. Cancers 13 (6) (2021)
Elettra Barberis, Sara Timo, Elia Amede, Virginia V Vanella, Chiara Puricelli, Annalisa Chiocchetti, Davide Raineri, Micol G Cittone, Eleonora Rizzi, Anita R Pedrinelli, Veronica Vassia, Francesco G Casciaro, Simona Priora, Ilaria Nerici, Alessandra Galbiati, Eyal Hayden, Marco Falasca, Rosanna Vaschetto, Pier Paolo Sainaghi, Umberto Dianzani, Roberta Rolla, Annalisa Chiocchetti, Gianluca Baldanzi, Emilio Marengo, Marcello Manfredi
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2. International journal of molecular sciences 21 (22) (2020)
Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, Tania Maffucci, Luc Furic, Federica Guffanti, Massimo Broggini, Xi Chen, Yulia Y Maxuitenko, Adam B Keeton, Gary A Piazza, Kenneth J Linton, Marco Falasca
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy. Cancers 12 (8) (2020)
Omar Elaskalani, Alice Domenichini, Norbaini Binti Abdol Razak, Danielle E Dye, Marco Falasca, Pat Metharom
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells. Cancers 12 (1) (2020)
Tania Maffucci, Marco Falasca
Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling. International journal of molecular sciences 21 (19) (2020)
Alice Domenichini, Ilaria Casari, Peter V Simpson, Nima Maheshkumar Desai, Lingfeng Chen, Christopher Dustin, Jeanne S Edmands, Albert van der Vliet, Moosa Mohammadi, Massimiliano Massi, Marco Falasca
Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Tania Maffucci, Marco Falasca
Signalling Properties of Inositol Polyphosphates. Molecules (Basel, Switzerland) 25 (22) (2020)
Yeuan Ting Lee, Yi Jer Tan, Marco Falasca, Chern-Ein Oon
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer. Cancers 12 (10) (2020)
Ilaria Casari, Alice Domenichini, Simona Sestito, Emily Capone, Gianluca Sala, Simona Rapposelli, Marco Falasca
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. Cancers 11 (11) (2019)
Andrea L Marat, Alexander Wallroth, Wen-Ting Lo, Rainer Müller, Giuseppe Danilo Norata, Marco Falasca, Carsten Schultz, Volker Haucke
mTORC1 activity repression by late endosomal phosphatidylinositol 3,4-bisphosphate. Science (New York, N.Y.) 356 (6341) (2018)
Peter V Simpson, Ilaria Casari, Silvano Paternoster, Brian W Skelton, Marco Falasca, Massimiliano Massi
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (27) (2017)
Omar Elaskalani, Marco Falasca, Niamh Moran, Michael C Berndt, Pat Metharom
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance. Cancers 9 (10) (2017)
Aikaterini Emmanouilidi, Marco Falasca
Targeting PDK1 for Chemosensitization of Cancer Cells. Cancers 9 (10) (2017)

Marco Falasca.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Falasca